|
1
|
Flores A and Marrero JA: Emerging trends
in hepatocellular carcinoma: Focus on diagnosis and therapeutics.
Clin Med Insights Oncol. 8:71–76. 2014.PubMed/NCBI
|
|
2
|
Chang PE, Ong WC, Lui HF and Tan CK: Is
theprognosis of young patients with hepatocellular carcinoma poorer
than the prognosis of older patients? A comparative analysis of
clinical characteristics, prognostic features, and survival
outcome. J Gastroenterol. 43:881–888. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rasool M, Rashid S, Arooj M, Ansari SA,
Khan KM, Malik A, Naseer MI, Zahid S, Manan A, Asif M, et al: New
possibilities in hepatocellular carcinoma treatment. Anticancer
Res. 34:1563–1571. 2014.PubMed/NCBI
|
|
4
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rust C and Gores GJ: Locoregional
management of hepatocellular carcinoma. Surgical and ablation
therapies. Clin Liver Dis. 5:161–173. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brown MR, Farquhar-Smith P, Williams JE,
ter Haar G and deSouza NM: The use of high-intensity focused
ultrasound as a novel treatment for painful conditions - a
description and narrative review of the literature. Br J Anaesth.
115:520–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Deng J, Feng J and Wu F:
Enhancement of antitumor vaccine in ablated hepatocellular
carcinoma by high-intensity focused ultrasound. World J
Gastroenterol. 16:3584–3591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang L, Yan L, Wen T, Li B, Zeng Y, Yang
J, Wang W, Xu M and Wu H: Comparison of outcomes of hepatic
resection and radiofrequency ablation for hepatocellular carcinoma
patients with multifocal tumors meeting the Barcelona-Clinic Liver
Cancer stage A classification. J Am Coll Surg. 221:951–961. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhong X, Lim EA, Hershman DL, Moinpour CM,
Unger J, Lee SM, Zhong X, Lim EA, Hershman DL, Moinpour CM, et al:
ReCAP: Identifying severe adverse event clusters using the National
Cancer Institute's Common Terminology Criteria for Adverse Events.
J Oncol Pract. 12:245–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song T: Recent advances in surgical
treatment of hepatocellular carcinoma. Drug Discov Ther. 9:319–330.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hołówko W, Wróblewski T, Wojtaszek M, Grąt
M, Kobryń K, Ziarkiewicz-Wróblewska B and Krawczyk M: Transarterial
chemoembolization prior to liver transplantation in patients with
hepatocellular carcinoma. Ann Transplant. 20:764–768. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyahara K, Nouso K and Yamamoto K:
Chemotherapy for advanced hepatocellular carcinoma in the sorafenib
age. World J Gastroenterol. 20:4151–4159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee SH, Kim SU, Jang JW, Bae SH, Lee S,
Kim BK, Park JY, Kim Do Y, Ahn SH and Han KH: Use of transient
elastography to predict de novo recurrence after radiofrequency
ablation for hepatocellular carcinoma. Onco Targets Ther.
8:347–356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ten Eikelder HM, Bošnački D, Elevelt A,
Donato K, Di Tullio A, Breuer BJ, van Wijk JH, van Dijk EV, Modena
D, Yeo SY and Grüll H: Modelling the temperature evolution of bone
under high intensity focused ultrasound. Phys Med Biol.
61:1810–1828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de Greef M, Schubert G, Wijlemans JW,
Koskela J, Bartels LW, Moonen CT and Ries M: Intercostal high
intensity focused ultrasound for liver ablation: The influence of
beam shaping on sonication efficacy and near-field risks. Med Phys.
42:4685–4697. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li CC, Wang YQ, Li YP and Li XL:
High-intensity focused ultrasound for treatment of pancreatic
cancer: A systematic review. J Evid Based Med. 7:270–281. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu
H and Wang ZB: Pathological changes in human malignant carcinoma
treated with high-intensity focused ultrasound. Ultrasound Med
Biol. 27:1099–1106. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blana A, Walter B, Rogenhofer S and
Wieland WF: High-intensity focused ultrasound for the treatment of
localized prostate cancer: 5-year experience. Urology. 63:297–300.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang W, Wang Y, Wang T, Wang J, Wang L and
Tang J: Safety and efficacy of US-guided high-intensity focused
ultrasound for treatment of submucosal fibroids. Eur Radiol.
22:2553–2558. 2012. View Article : Google Scholar : PubMed/NCBI
|
